The antiretroviral therapy (ART) coverage in Brazil has shown consistent growth over the past decade. In 2023, ART coverage stood at 76 units of persons living with HIV. The year-on-year variation from 2013 to 2023 reveals fluctuations, with an average Compounded Annual Growth Rate (CAGR) over the last five years of 2.25%. This indicates a stable yet slightly decelerating growth trend.
Analyzing the more recent years, from 2021 to 2023, there is a noticeable average annual increase of approximately 2.30%, demonstrating steady progress. Transitioning to forecasted data from 2024 to 2028, the CAGR is projected to slow to 1.02%, reflecting a growth rate of 5.19% over the five-year period.
Future trends to watch for include potential impacts of new policies, advancements in treatment methodologies, and integration of innovative healthcare technologies. Monitoring these factors will be essential to understanding how ART coverage may further evolve in Brazil.
